Table 4.
75–79 y | 80–84 y | ≥85 y | |
---|---|---|---|
Predictors | OR (95% CI) | OR (95% CI) | OR (95% CI) |
Age (per 1-year increase) | 1.14 (1.12–1.16) | 1.08 (1.06–1.10) | 0.99 (0.99–1.00) |
Female | 1.19 (1.14–1.25) | 1.23 (1.17–1.29) | 1.12 (1.06–1.19) |
Cerebrovascular disease | 1.25 (1.18–1.32) | 1.13 (1.08–1.19) | 1.06 (1.00–1.13) |
Diabetes mellitus | 1.12 (1.06–1.17) | 0.98 (0.93–1.03) | 0.97 (0.91–1.03) |
Ischemic heart disease | 0.99 (0.92–1.05) | 1.01 (0.95–1.07) | 0.96 (0.90–1.03) |
Atrial fibrillation | 1.06 (0.97–1.16) | 0.95 (0.87–1.02) | 0.87 (0.79–0.96) |
Depression or use of antidepressants at baseline | 1.47 (1.36–1.59) | 1.38 (1.28–1.49) | 1.21 (1.10–1.32) |
Use of antipsychotics at baseline |
1.48 (1.33–1.64) | 1.40 (1.25–1.56) | 1.31 (1.15–1.49) |
Use of anxiolytics at baseline | 1.03 (0.97–1.10) | 0.95 (0.89–1.01) | 0.97 (0.91–1.05) |
Use of hypnotics at baseline | 1.17 (1.07–1.28) | 1.19 (1.10–1.30) | 1.16 (1.04–1.29) |
Use of antihypertensive drugs at baseline |
0.89 (0.85–0.94) | 0.89 (0.85–0.93) | 0.90 (0.85–0.95) |
Use of dyslipidemia drugs at baseline |
0.87 (0.83–0.92) | 0.92 (0.88–0.97) | 0.96 (0.91–1.02) |
Use of antithrombotics at baseline |
1.09 (1.02–1.15) | 1.05 (0.99–1.11) | 1.01 (0.94–1.07) |
Abbreviations: OR, odds ratio; CI, confidence interval.